Blue Ocean Capital Group

Blue Ocean Capital Group is an emerging private equity investment firm, focusing on the healthcare industry, with cumulative management of over $300 million worth of RMB and USD dual-currency funds. The firm adheres to deep investment and value creation, bringing positive changes to invested companies and creating long-term value for investors. Blue Ocean Capital Group has been recognized with several awards, including being listed in the Top 10 New Private Equity Investment Institutions in China in 2015 and receiving the Best M&A Financing Award in 2017. The investment strategy revolves around specializing in early-stage and growth-stage healthcare industry investments, while persistently pursuing deep investment and value creation. The core investment team boasts an international, multi-dimensional group with extensive backgrounds in investment and pharmaceutical industries, as well as consulting firms. This team has accumulated excellent investment records worth over $1 billion in the pharmaceutical industry and possesses over 100 years of investment and industry experience. Furthermore, they have vast experience in capital markets, cross-border investments, and mergers and acquisitions. The firm offers in-depth value-added services, including strategic support for enterprise development, M&A value-added services, enterprise financing support, and capital market strategy services. Blue Ocean Capital Group's strong network extends to the pharmaceutical and medical industry, industrial parks, research institutions, commercial and investment banks, consulting firms, and government agencies. Founded in 2015 and headquartered in China, Blue Ocean Capital Group presents a promising opportunity for investors looking to tap into the growing healthcare industry in both China and globally.